We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ARVN market cap is 545.98M. The company's latest EPS is USD -2.7250 and P/E is -2.74.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 25.3M | 76.5M | 102.4M | 59.2M | 188.8M |
| Operating Income | -83.3M | -48.5M | -60.2M | -53.6M | 74M |
| Net Income | -69.4M | -35.2M | -49.2M | -45.1M | 82.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.8M | 46.7M | 131.4M | 78.5M | 263.4M |
| Operating Income | -124.86M | -195.3M | -273.8M | -404M | -245.6M |
| Net Income | -119.33M | -191M | -282.5M | -367.3M | -198.9M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.21B | 1.28B | 1.17B | 1.09B | 1B |
| Total Liabilities | 602.9M | 679.4M | 581.1M | 529.7M | 341M |
| Total Equity | 609.7M | 600.2M | 586M | 561.7M | 660.1M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 717.37M | 1.58B | 1.27B | 1.3B | 1.09B |
| Total Liabilities | 75.11M | 799.9M | 703.9M | 644.6M | 529.7M |
| Total Equity | 642.26M | 781.7M | 564.9M | 660M | 561.7M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -97.7M | -47.2M | -175.2M | -259.3M | -88.9M |
| Investing | -127.8M | -114.7M | -64.2M | 34.7M | 69.5M |
| Financing | 1.6M | 5M | 7.4M | 7.9M | -100k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -89.76M | 559.4M | -273.5M | -347.8M | -259.3M |
| Investing | 164.25M | -1.31B | 242.8M | 203.5M | 34.7M |
| Financing | 504.67M | 278.6M | 4.7M | 374.7M | 7.9M |
| Market Cap | 545.98M |
| Price to Earnings Ratio | -2.74 |
| Price to Sales Ratio | 2.07 |
| Price to Cash Ratio | 5.43 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 72.99M |
| Average Volume (1 week) | 1.71M |
| Average Volume (1 Month) | 2.23M |
| 52 Week Change | -69.83% |
| 52 Week High | 34.11 |
| 52 Week Low | 5.90 |
| Spread (Intraday) | 0.57 (7.14%) |
| Company Name | Arvinas Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.arvinas.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
